WT1 and acute myeloid leukemia: For most of the AML patients (5 out of 7 analyzed patients), only few WT1-specific CD8 + T-cells were discovered in their BM samples; therefore, we investigated the implications of patients’ HLA-A allele on WT1 peptide presentation.